Prioritization of evidence-based indications for intravenous immunoglobulin

静脉注射免疫球蛋白循证适应症的优先排序

阅读:1

Abstract

To estimate the cost of the migraine patient in Italy, we undertook an observational, multicenter study. The study was carried out by 902 Italian general practitioners (GPs). GPs asked patients over 14 years of age who came to their surgeries whether they suffered from headaches. If so, the doctor questioned the patient to determine whether he or she was a migraineur according to the IHS criteria. Migraineurs entered a 2-month follow-up programme. GPs interviewed 72 038 patients, of which 4794 were migraineurs. Migraineurs received a diary card to record attacks and the treatment they took. During the two scheduled monthly meetings with the doctor, patients and GPs recorded on diary cards the use of healthcare resources and working days lost due to migraine. Overall, the annual cost of migraine per patient was Lit 1 159 840 (605.03 USD). Our study shows that the overall cost of migraine to the community is very high. Direct costs are higher than in other countries.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。